Life-long follow up for second cancers seems needed for childhood ALL survivors

Categories: Cancer Treatment

Thirty years after treatment for childhood acute lymphoblastic leukemia (ALL), survivors remain at increased risk for developing a second malignancy, according to a new report.

“Today, prognosis from childhood ALL is excellent, so now, more and more patients become long-term survivors,” Dr. Nobuko Hijiya from St. Jude Children’s Research Hospital, Memphis, Tennessee.

Until now, little was known about the incidence of secondary cancers beyond 15 to 20 years in childhood ALL survivors, she added.

You Might Like:
  • High-dose chemo doesn’t improve survival in metastatic breast cancer
  • Comorbidity reduces benefits of androgen suppression in prostate cancer
  • Statins don’t appear to be linked with breast cancer risk
  • Soft-tissue sarcoma outcomes vary widely by race, ethnicity
  • Even small copay deters mammogram use: U.S. study
  • Effective prostate cancer screening requires digital rectal exam
  • Clinical trial access more limited for teen cancer patients
  • MicroRNA signatures linked with AML prognosis, cytogenetics
  • Stop-and-go oxaliplatin effective in elderly colon cancer patients
  • In vitro fertilization safe in women treated for endometrial carcinoma
  • High-dose methotrexate effective treatment for primary CNS lymphoma
  • Docetaxel every three weeks best for certain metastatic prostate cancers
  • Chewing gum after cystectomy stimulates return of bowel motility
  • Surgeon factors affect receipt of radiotherapy for breast cancer
  • Multimodal treatment may help in invasive bladder cancer
    •

    Leave a Reply

    « Supracervical hysterectomy alternative for ovarian cancer
    Radiotherapy may be preferable to surgery after chemotherapy for lung cancer »